Search earnings tickers

GILD

2024Q4AMC

Gilead Sciences Inc primary · HEALTHCARE · DRUG MANUFACTURERS - GENERAL

Report 2025-02-11 · Fiscal end 2024-12-31 · Features as of 2025-02-11

← Earnings history

Street

Consensus EPS1.701

Consensus rev—

EPS high—

EPS low—

Dispersion—

Analysts—

EPS rev net 7d—

EPS rev net 30d—

Consensus Δ 7d—

Consensus Δ 30d—

Options

Implied move2.1%

IV front—

P/C full—

P/C front—

Features as of2025-02-11

Run-up

Close—

Ret 5d-1.9%

Ret 10d+2.4%

Ret 20d+6.9%

Ret 30d+1.8%

Print

Actual EPS

1.90Beat

Estimated EPS1.701

Actual revenue

7.6B

Surprise %+11.7%

Beat / missBeat

Beat streak 44

Beat streak 84

Reaction

1-day stock reaction+1.5%

Implied vs actual

Implied 2.1%Actual 5.8%

Gap reaction+5.8%

Day result+7.5%

Next-day upYes

Realized / IV2.71×

Post tape

Post 5d+6.5%

Post 10d+8.4%

Post volume16.2M

Vol ×10d2.25×

Vol ×20d2.22×

Post range3.8%